About 6 results found for searched term "Androgen receptor antagonist 8" (0.127 seconds)
Cat.No. | Name | Target |
---|---|---|
M43584 | Androgen receptor antagonist 8 | Androgen Receptor |
Androgen receptor antagonist 8 is an androgen receptor antagonist. | ||
M2717 | Galeterone | Androgen Receptor |
TOK-001 | ||
Galeterone is a selective CYP17 inhibitor and androgen receptor (AR) antagonist with IC50 of 300 nM and 384 nM, respectively, and is a potent inhibitor of human prostate tumor growth. | ||
M10965 | ORM-15341 | Androgen Receptor |
ORM-15341 is a potent androgen receptor (AR) antagonist that acts on AR-HEK293 cells with an IC50 value of 38 nM. | ||
M28616 | Rezvilutamide | Androgen Receptor |
SHR3680 | ||
Rezvilutamide (SHR3680) is an androgen receptor antagonist. Rezvilutamide (SHR3680) is used for the study of prostate cancer. | ||
M29317 | UT-34 | Androgen Receptor |
UT-34 is a potent, selective and orally active second-generation pan-androgen receptor (AR) antagonist and degrader with IC50s of 211.7 nM, 262.4 nM and 215.7 nM for wild-type, F876L and W741L AR, respectively. UT-34 binds to ligand-binding domain (LBD) and function-1 (AF-1) domains and requires ubiquitin proteasome pathway to degrade the AR. UT-34 has anti-prostate cancer efficacy. | ||
M29958 | AR antagonist 3 | Androgen Receptor |
AR antagonist 3 is a potent and selective androgen receptor (AR) antagonist with an IC50 of 0.47 µM. AR antagonist 3 exhibits a dose-dependent decrease of the FRET signal (IC50= 18.05 μM). AR antagonist 3 shows effective inhibition on tumor growth when administered intratumorally. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.